Harold E. Brakewood - Feb 8, 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Chief Business Officer
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Harold E. Brakewood
Stock symbol
IMRX
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 04:21 PM
Previous filing
Apr 3, 2023
Next filing
Mar 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +60.5K $0.00 60.5K Feb 8, 2024 Class A Common Stock 60.5K $6.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.